Radiofrequency therapy at 448 kHz for persisting pain after episiotomy * a pilot study

Withdrawn

• Conditions: episiotomy; vaginal cut; 10036411; 10029903

• Registration Number: NL-OMON51265
• Lead Sponsor: Ikazia Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 32

Inclusion Criteria

1. Age * 18 years
2. Persisting pain in the pelvic floor region (VAS-score * 4) after a
mediolateral episiotomy
3. At least 6 weeks after delivery

Exclusion Criteria

1. Signs of infection of the episiotomy wound
2. Pacemaker or other electronical implant
3. Nickel allergy
4. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is to compare VAS scores before and after MCRRF therapy. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints are reassumption of sexual intercourse and analgesics<br /><br>intake.</p><br>